Publicaciones en colaboración con investigadores/as de Gustave Roussy Cancer Campus (13)

2023

  1. Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease

    Cells, Vol. 12, Núm. 5

2021

  1. Clonogenic Assays to Detect Cell Fate in Mitotic Catastrophe

    Methods in Molecular Biology (Humana Press Inc.), pp. 227-239

2020

  1. Metabolic alterations in plasma from patients with familial and idiopathic Parkinson's disease

    Aging, Vol. 12, Núm. 17, pp. 16690-16708

2014

  1. Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, Núm. 8, pp. 3020-3025

2013

  1. Antiapoptotic activity of argon and xenon

    Cell Cycle, Vol. 12, Núm. 16, pp. 2636-2642

  2. Transgenerational cell fate profiling: A method for the graphical presentation of complex cell cycle alterations

    Cell Cycle, Vol. 12, Núm. 1, pp. 183-190

2012

  1. An immunosurveillance mechanism controls cancer cell ploidy

    Science, Vol. 337, Núm. 6102, pp. 1678-1684

  2. Autophagic removal of micronuclei

    Cell Cycle, Vol. 11, Núm. 1, pp. 170-176

  3. Selective killing of p53-deficient cancer cells by SP600125

    EMBO Molecular Medicine, Vol. 4, Núm. 6, pp. 500-514

2011

  1. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

    Science, Vol. 334, Núm. 6062, pp. 1573-1577

2010

  1. An automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe

    Cell Death and Disease, Vol. 1, Núm. 2

  2. Involvement of p38α in the mitotic progression of p53-/- tetraploid cells

    Cell Cycle, Vol. 9, Núm. 14, pp. 2895-2901

  3. Multipolar mitosis of tetraploid cells: Inhibition by p53 and dependency on Mos

    EMBO Journal, Vol. 29, Núm. 7, pp. 1272-1284